HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increased LDL electronegativity in chronic kidney disease disrupts calcium homeostasis resulting in cardiac dysfunction.

Abstract
Chronic kidney disease (CKD), an independent risk factor for cardiovascular disease, is associated with abnormal lipoprotein metabolism. We examined whether electronegative low-density lipoprotein (LDL) is mechanistically linked to cardiac dysfunction in patients with early CKD. We compared echocardiographic parameters between patients with stage 2 CKD (n = 88) and normal controls (n = 89) and found that impaired relaxation was more common in CKD patients. Reduction in estimated glomerular filtration rate was an independent predictor of left ventricular relaxation dysfunction. We then examined cardiac function in a rat model of early CKD induced by unilateral nephrectomy (UNx) by analyzing pressure-volume loop data. The time constant of isovolumic pressure decay was longer and the maximal velocity of pressure fall was slower in UNx rats than in controls. When we investigated the mechanisms underlying relaxation dysfunction, we found that LDL from CKD patients and UNx rats was more electronegative than LDL from their respective controls and that LDL from UNx rats induced intracellular calcium overload in H9c2 cardiomyocytes in vitro. Furthermore, chronic administration of electronegative LDL, which signals through lectin-like oxidized LDL receptor-1 (LOX-1), induced relaxation dysfunction in wild-type but not LOX-1(-/-) mice. In in vitro and in vivo experiments, impaired cardiac relaxation was associated with increased calcium transient resulting from nitric oxide (NO)-dependent nitrosylation of SERCA2a due to increases in inducible NO synthase expression and endothelial NO synthase uncoupling. In conclusion, LDL becomes more electronegative in early CKD. This change disrupts SERCA2a-regulated calcium homeostasis, which may be the mechanism underlying cardiorenal syndrome.
AuthorsKuan-Cheng Chang, An-Sheng Lee, Wei-Yu Chen, Yen-Nien Lin, Jing-Fang Hsu, Hua-Chen Chan, Chia-Ming Chang, Shih-Sheng Chang, Chia-Chi Pan, Tatsuya Sawamura, Chi-Tzong Chang, Ming-Jai Su, Chu-Huang Chen
JournalJournal of molecular and cellular cardiology (J Mol Cell Cardiol) Vol. 84 Pg. 36-44 (Jul 2015) ISSN: 1095-8584 [Electronic] England
PMID25871829 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Ltd. All rights reserved.
Chemical References
  • Lipoproteins, LDL
  • Receptors, Oxidized LDL
  • oxidized low density lipoprotein
  • tau Proteins
  • Nitric Oxide Synthase Type II
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases
  • Calcium
Topics
  • Adult
  • Animals
  • Calcium (metabolism)
  • Case-Control Studies
  • Demography
  • Female
  • Fibrosis
  • Heart
  • Homeostasis
  • Humans
  • Lipoproteins, LDL (metabolism)
  • Male
  • Mice, Inbred C57BL
  • Models, Biological
  • Myocytes, Cardiac (metabolism)
  • Nephrectomy
  • Nitric Oxide Synthase Type II (metabolism)
  • Nitrosation
  • Rats, Sprague-Dawley
  • Receptors, Oxidized LDL (metabolism)
  • Renal Insufficiency, Chronic (diagnostic imaging, metabolism, physiopathology)
  • Renin-Angiotensin System
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases (metabolism)
  • Ultrasonography
  • Up-Regulation
  • Vasodilation
  • tau Proteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: